Pernix Therapeutics
Pernix Therapeutics
Employees:
180
Market Cap:
$20.91 million
Revenue:
$146.04 million
5 Year Trend:
18.9%
Net Income:
$-101.64 million
Stock:
PTX

Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. Wikipedia

Pernix Therapeutics
Are you from Pernix Therapeutics?

Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. Wikipedia

Employees:
180
Market Cap:
$20.91 million
Revenue:
$146.04 million
5 Year Trend:
18.9%
Net Income:
$-101.64 million
Stock:
PTX

3 jobs at Pernix Therapeutics

Jobs in